FindMyKOL
Clinical trialNCT00867854CompletedObservational

Treatment De-Intensification and Residual HIV-1 in Youth

NCT00867854 is an observational study sponsored by University of North Carolina, Chapel Hill. As of 21 Nov 2026, it is completed. It studies HIV Infections and HIV-1. The registry lists an enrollment of 34 participants at 17 sites in 2 countries. The registry lists a start date of 28 Feb 2009 and a primary completion date of 31 Oct 2011.

SponsorUniversity of North Carolina, Chapel HillEnrollment34HIV InfectionsHIV-1
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT00867854
FieldValue
Registry IDNCT00867854
StatusCompleted
Study typeObservational study
Lead sponsorUniversity of North Carolina, Chapel Hill
Enrollment34
Registered sites17
Countries2
ConditionsHIV Infections and HIV-1
Start28 Feb 2009
Primary completion31 Oct 2011
Study completion31 Oct 2011
Last update posted28 Feb 2017

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This laboratory-based sub-study of ATN 061 and ATN 071 will examine the effect of early treatment followed by treatment de-intensification to atazanavir/ritonavir (ATV/r) monotherapy on steady-state frequencies of replication-competent CD4+ T cell Human Immunodeficiency Virus (HIV)-1 reservoirs or cell-associated infectivity (CAI) and persistent low-level viremia (LLV), and their contribution to successful long-term control of HIV-1 replication among HIV-1 infected adolescents and young adults.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States2 sites
  • Children's Hospital of Los Angeles

    Los Angeles

  • University of California at San Francisco

    San Francisco

District of Columbia, United States2 sites
  • Children's National Medical Center

    Washington D.C.

  • Howard University - Impaact Site

    Washington D.C.

Florida, United States3 sites
  • Children's Diagnostic and Teatment Center

    Fort Lauderdale

  • University of Miami School of Medicine

    Miami

  • University of South Florida College of Medicine

    Tampa

Illinois, United States2 sites
  • Children's Memorial Hospital

    Chicago

  • John Stroger Jr. Hospital of Cook County

    Chicago

Louisiana, United States1 site
  • Tulane Medical Center

    New Orleans

Maryland, United States2 sites
  • Johns Hopkins University - Impaact Site

    Baltimore

  • University of Maryland

    Baltimore

New York, United States2 sites
  • Mount Sinai Medical Center

    New York

  • Montefiore Medical Center

    The Bronx

Pennsylvania, United States1 site
  • Children's Hospital of Philadelphia

    Philadelphia

Tennessee, United States1 site
  • St. Jude Children's Research Hospital

    Memphis

Puerto Rico1 site
  • University of Puerto Rico

    San Juan

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew York: 2 sitesNY2MassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinois: 2 sitesIL2IndianaINOhioOHPennsylvania: 1 sitePA1New JerseyNJConnecticutCTCalifornia: 2 sitesCA2NevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMaryland: 2 sitesMD2DelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennessee: 1 siteTN1North CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisiana: 1 siteLA1MississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFlorida: 3 sitesFL3District of Columbia: 2 sitesDC2
Fewer sitesMore sites

Outside the United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT00867854

Each answer restates registry values shown on this page.

What is NCT00867854?

NCT00867854 is an observational study sponsored by University of North Carolina, Chapel Hill. It studies HIV Infections and HIV-1.

Who leads NCT00867854?

The registry names Deborah Persaud, M.D. (study chair, Adolescent Trials Network) as the overall official.

Where does NCT00867854 run?

The registry lists 17 sites in 2 countries. Most sites are in these countries: United States (16) and Puerto Rico (1).

When did NCT00867854 end?

The registry lists a primary completion date of 31 Oct 2011 and a study completion date of 31 Oct 2011. The sponsor last updated the record on 28 Feb 2017.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.